Levi P Sowers1,2,3, Mengya Wang4, Brandon J Rea1,2,3, Rebecca J Taugher2,5, Adisa Kuburas3, Youngcho Kim6, John A Wemmie2,3,5,7, Christopher S Walker8, Debbie L Hay8,9, Andrew F Russo1,2,3,6. 1. Center for the Prevention and Treatment of Visual Loss, Iowa City, IA, USA. 2. Veterans Administration Health Center, Iowa City, IA, USA. 3. Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA, USA. 4. Department of Pharmacology, University of Iowa, Iowa City, IA, USA. 5. Department of Psychiatry, University of Iowa, Iowa City, IA, USA. 6. Department of Neurology, University of Iowa, Iowa City, IA, USA. 7. Department of Neurosurgery, University of Iowa, Iowa City, IA, USA. 8. School of Biological Sciences, University of Auckland, Auckland, New Zealand. 9. Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand.
Abstract
OBJECTIVE: A hallmark of migraine is photophobia. In mice, photophobia-like behavior is induced by calcitonin gene-related peptide (CGRP), a neuropeptide known to be a key player in migraine. In this study, we sought to identify sites within the brain from which CGRP could induce photophobia. DESIGN: We focused on the posterior thalamic region, which contains neurons responsive to both light and dural stimulation and has CGRP binding sites. We probed this area with both optogenetic stimulation and acute CGRP injections in wild-type mice. Since the light/dark assay has historically been used to investigate anxiety-like responses in animals, we measured anxiety in a light-independent open field assay and asked if stimulation of a brain region, the periaqueductal gray, that induces anxiety would yield similar results to posterior thalamic stimulation. The hippocampus was used as an anatomical control to ensure that light-aversive behaviors could not be induced by the stimulation of any brain region. RESULTS: Optogenetic activation of neuronal cell bodies in the posterior thalamic nuclei elicited light aversion in both bright and dim light without an anxiety-like response in an open field assay. Injection of CGRP into the posterior thalamic region triggered similar light-aversive behavior without anxiety. In contrast to the posterior thalamic nuclei, optogenetic stimulation of dorsal periaqueductal gray cell bodies caused both light aversion and an anxiety-like response, while CGRP injection had no effect. In the dorsal hippocampus, neither optical stimulation nor CGRP injection affected light aversion or open field behaviors. CONCLUSION: Stimulation of posterior thalamic nuclei is able to initiate light-aversive signals in mice that may be modulated by CGRP to cause photophobia in migraine.
OBJECTIVE: A hallmark of migraine is photophobia. In mice, photophobia-like behavior is induced by calcitonin gene-related peptide (CGRP), a neuropeptide known to be a key player in migraine. In this study, we sought to identify sites within the brain from which CGRP could induce photophobia. DESIGN: We focused on the posterior thalamic region, which contains neurons responsive to both light and dural stimulation and has CGRP binding sites. We probed this area with both optogenetic stimulation and acute CGRP injections in wild-type mice. Since the light/dark assay has historically been used to investigate anxiety-like responses in animals, we measured anxiety in a light-independent open field assay and asked if stimulation of a brain region, the periaqueductal gray, that induces anxiety would yield similar results to posterior thalamic stimulation. The hippocampus was used as an anatomical control to ensure that light-aversive behaviors could not be induced by the stimulation of any brain region. RESULTS: Optogenetic activation of neuronal cell bodies in the posterior thalamic nuclei elicited light aversion in both bright and dim light without an anxiety-like response in an open field assay. Injection of CGRP into the posterior thalamic region triggered similar light-aversive behavior without anxiety. In contrast to the posterior thalamic nuclei, optogenetic stimulation of dorsal periaqueductal gray cell bodies caused both light aversion and an anxiety-like response, while CGRP injection had no effect. In the dorsal hippocampus, neither optical stimulation nor CGRP injection affected light aversion or open field behaviors. CONCLUSION: Stimulation of posterior thalamic nuclei is able to initiate light-aversive signals in mice that may be modulated by CGRP to cause photophobia in migraine.
Authors: Ed S Lein; Michael J Hawrylycz; Nancy Ao; Mikael Ayres; Amy Bensinger; Amy Bernard; Andrew F Boe; Mark S Boguski; Kevin S Brockway; Emi J Byrnes; Lin Chen; Li Chen; Tsuey-Ming Chen; Mei Chi Chin; Jimmy Chong; Brian E Crook; Aneta Czaplinska; Chinh N Dang; Suvro Datta; Nick R Dee; Aimee L Desaki; Tsega Desta; Ellen Diep; Tim A Dolbeare; Matthew J Donelan; Hong-Wei Dong; Jennifer G Dougherty; Ben J Duncan; Amanda J Ebbert; Gregor Eichele; Lili K Estin; Casey Faber; Benjamin A Facer; Rick Fields; Shanna R Fischer; Tim P Fliss; Cliff Frensley; Sabrina N Gates; Katie J Glattfelder; Kevin R Halverson; Matthew R Hart; John G Hohmann; Maureen P Howell; Darren P Jeung; Rebecca A Johnson; Patrick T Karr; Reena Kawal; Jolene M Kidney; Rachel H Knapik; Chihchau L Kuan; James H Lake; Annabel R Laramee; Kirk D Larsen; Christopher Lau; Tracy A Lemon; Agnes J Liang; Ying Liu; Lon T Luong; Jesse Michaels; Judith J Morgan; Rebecca J Morgan; Marty T Mortrud; Nerick F Mosqueda; Lydia L Ng; Randy Ng; Geralyn J Orta; Caroline C Overly; Tu H Pak; Sheana E Parry; Sayan D Pathak; Owen C Pearson; Ralph B Puchalski; Zackery L Riley; Hannah R Rockett; Stephen A Rowland; Joshua J Royall; Marcos J Ruiz; Nadia R Sarno; Katherine Schaffnit; Nadiya V Shapovalova; Taz Sivisay; Clifford R Slaughterbeck; Simon C Smith; Kimberly A Smith; Bryan I Smith; Andy J Sodt; Nick N Stewart; Kenda-Ruth Stumpf; Susan M Sunkin; Madhavi Sutram; Angelene Tam; Carey D Teemer; Christina Thaller; Carol L Thompson; Lee R Varnam; Axel Visel; Ray M Whitlock; Paul E Wohnoutka; Crissa K Wolkey; Victoria Y Wong; Matthew Wood; Murat B Yaylaoglu; Rob C Young; Brian L Youngstrom; Xu Feng Yuan; Bin Zhang; Theresa A Zwingman; Allan R Jones Journal: Nature Date: 2006-12-06 Impact factor: 49.962
Authors: Shazia K Afridi; Nicola J Giffin; Holger Kaube; Karl J Friston; Nick S Ward; Richard S J Frackowiak; Peter J Goadsby Journal: Arch Neurol Date: 2005-08
Authors: Rodrigo Noseda; Alice J Lee; Rony-Reuven Nir; Carolyn A Bernstein; Vanessa M Kainz; Suzanne M Bertisch; Catherine Buettner; David Borsook; Rami Burstein Journal: Proc Natl Acad Sci U S A Date: 2017-06-26 Impact factor: 11.205
Authors: Ana Recober; Adisa Kuburas; Zhongming Zhang; John A Wemmie; Michael G Anderson; Andrew F Russo Journal: J Neurosci Date: 2009-07-08 Impact factor: 6.167
Authors: Carolyn A Bernstein; Rony-Reuven Nir; Rodrigo Noseda; Anne B Fulton; Shaelah Huntington; Alice J Lee; Suzanne M Bertisch; Alexandra Hovaguimian; Catherine Buettner; David Borsook; Rami Burstein Journal: Pain Date: 2019-03 Impact factor: 7.926
Authors: Mengya Wang; Bianca N Mason; Levi P Sowers; Adisa Kuburas; Brandon J Rea; Andrew F Russo Journal: J Vis Exp Date: 2021-08-11 Impact factor: 1.424
Authors: Mengya Wang; William C Castonguay; Thomas L Duong; Michael W Huebner; Harold C Flinn; Agatha M Greenway; Andrew F Russo; Levi P Sowers Journal: Neurobiol Pain Date: 2022-06-23
Authors: Mengya Wang; Thomas L Duong; Brandon J Rea; Jayme S Waite; Michael W Huebner; Harold C Flinn; Andrew F Russo; Levi P Sowers Journal: Front Pain Res (Lausanne) Date: 2022-04-25